Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Agendia co-founder to be honored with 2014 European Union Prize for Women Innovators

Agendia co-founder Laura van 't Veer, Ph.D., will receive a 2014 European Union Prize for Women Innovators in ceremonies next Monday. Dr. van 't Veer, of the Netherlands, is the inventor of Agendia's MammaPrint® breast cancer test.

7 Mar 2014

TAZ gene represents potential target for drug therapies to treat aggressive types of breast cancer

Significance: Understanding more about how the different types of cells in breast tissue develop improves our knowledge of breast cancer. TAZ represents a potential new target for drug therapies to treat aggressive types of breast cancer.

7 Mar 2014

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Incyte Corporation (Nasdaq: INCY) today announced that a pivotal Phase III trial of ruxolitinib compared to best available therapy in patients with polycythemia vera who are resistant to or intolerant of hydroxyurea has met its primary endpoint of achieving phlebotomy independence and reducing spleen size by 35 percent or more.

7 Mar 2014

Researchers examine association between diabetes and obesity

It's by now well established that obesity is a major risk factor for diabetes. But what exactly is it about extra body fat that leads to insulin resistance and blood glucose elevation, the hallmarks of diabetes?

7 Mar 2014

Research reveals 2 key mechanisms of oxidative stress regulation

Regulation of oxidative stress is critical to cell survival. New preclinical research from Roswell Park Cancer Institute (RPCI) has revealed two key mechanisms by which oxidative stress is regulated in normal and cancerous cells.

7 Mar 2014

Ludwig, Agenus to advance three monoclonal antibody checkpoint modulators into preclinical development

Ludwig Cancer Research and Agenus Inc. today announced the selection of three monoclonal antibody checkpoint modulators (CPMs) that Agenus is advancing into preclinical development.

7 Mar 2014

Elsevier launches medical reference and learning platforms for clinicians, students

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the fully redesigned Expert Consult and Student Consult, its two medical reference and learning platforms, now powered by Inkling, the creator of engaging, intuitive digital books for some of the world's most respected publishers.

6 Mar 2014

Scientists develop reliable way of detecting prostate and bladder cancers

A new licence announced today between the University of Surrey and Randox, will bring to market a new test that will help with the early detection of prostate and bladder cancers.

From Randox Laboratories Ltd. 6 Mar 2014

New guidelines developed to help patients better understand cancer consultations

The experiences of doctors, patients and carers of initial cancer consultations have informed new guidelines developed at the University of Leicester, in collaboration with University Hospitals of Leicester NHS Trust and Imperial College London, to help patients better understand their cancer consultations.

6 Mar 2014

ASTRO white paper recommends specific guidance to follow in the delivery of HDR brachytherapy

The American Society for Radiation Oncology has issued a new white paper, "A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy," that recommends specific guidance to follow in the delivery of high-dose-rate (HDR) brachytherapy to improve quality and patient safety, according to the manuscript published in the March-April 2014 print issue of Practical Radiation Oncology, the official clinical practice journal of ASTRO.

6 Mar 2014

Novel cancer immunotherapy approach may provide new weapon against most deadly tumors

A novel approach to cancer immunotherapy - strategies designed to induce the immune system to attack cancer cells - may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.

6 Mar 2014

Washington Hospital recognized as 'Baby-Friendly Hospital'

Washington Hospital has earned the distinction as a "Baby-Friendly Hospital" from the Baby-Friendly Hospital Initiative, a global program launched by the World Health Organization and the United Nations Children's Fund. The designation recognizes hospitals and birthing centers that offer an optimal level of care for infant feeding and mother/baby bonding. Fewer than 175 hospitals in the U.S. are "Baby-Friendly."

6 Mar 2014

Verastem presents preliminary data from VS-6063 Phase 1 trial in Japanese patients with solid tumors

Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today presented preliminary data from an ongoing First-in-Asia Phase 1 trial of VS-6063 in Japanese patients with advanced solid tumors, including one patient with mesothelioma. The Phase 1 study assessed the safety and pharmacokinetics of single agent VS-6063.

5 Mar 2014

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Agenus Inc., a biopharmaceutical company developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, today announced its financial results and business highlights for the fourth quarter and year ended December 31, 2013.

5 Mar 2014

Minimally invasive surgery outcomes show favorable results in low back pain patients

Beaumont research findings published in the February online issue of Spine shows that patients who have a low back surgery called minimally invasive transforaminal lumbar interbody fusion, end up better off in many ways than patients who have more invasive surgery to alleviate debilitating pain.

5 Mar 2014

Set of genes appear to predict which tumors can evade detection by immune system

Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.

5 Mar 2014

$Researchers develop silk-based surgical plates and screws to repair bone fractures$

Researchers develop silk-based surgical plates and screws to repair bone fractures

When a person suffers a broken bone, treatment calls for the surgeon to insert screws and plates to help bond the broken sections and enable the fracture to heal. These "fixation devices" are usually made of metal alloys.

5 Mar 2014

Dr. Reddy's Laboratories launches Moxifloxacin Hydrochloride Tablets

Dr. Reddy's Laboratories Ltd. announced today that it has launched Moxifloxacin Hydrochloride Tablets, 400 mg, a therapeutic equivalent generic version of Avelox (moxifloxacin HCl) tablets 400 mg in the US market on March 04, 2014, following the approval by the United States Food & Drug Administration.

5 Mar 2014

Researchers identify genes that appear to predict tumors that can evade detection by immune system

Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body’s immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.

5 Mar 2014

Researchers find antibody that may be used in future treatments for recurrent small-cell lung cancer

Researchers at Norris Cotton Cancer Center have found an antibody that may be used in future treatments for recurrent small-cell lung cancer, which currently has no effective therapy.

5 Mar 2014

Oncology News and Research

Further Reading

Agendia co-founder to be honored with 2014 European Union Prize for Women Innovators

TAZ gene represents potential target for drug therapies to treat aggressive types of breast cancer

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Researchers examine association between diabetes and obesity

Research reveals 2 key mechanisms of oxidative stress regulation

Ludwig, Agenus to advance three monoclonal antibody checkpoint modulators into preclinical development

Elsevier launches medical reference and learning platforms for clinicians, students

Scientists develop reliable way of detecting prostate and bladder cancers

New guidelines developed to help patients better understand cancer consultations

ASTRO white paper recommends specific guidance to follow in the delivery of HDR brachytherapy

Novel cancer immunotherapy approach may provide new weapon against most deadly tumors

Washington Hospital recognized as 'Baby-Friendly Hospital'

Verastem presents preliminary data from VS-6063 Phase 1 trial in Japanese patients with solid tumors

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Minimally invasive surgery outcomes show favorable results in low back pain patients

Set of genes appear to predict which tumors can evade detection by immune system

Researchers develop silk-based surgical plates and screws to repair bone fractures

Dr. Reddy's Laboratories launches Moxifloxacin Hydrochloride Tablets

Researchers identify genes that appear to predict tumors that can evade detection by immune system

Researchers find antibody that may be used in future treatments for recurrent small-cell lung cancer

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News